France Gauthier

Centre Hospitalier de l’Université de Montréal

Papers

1

Total Citations

84

H-Index

1

About

France Gauthier is a leading gynecologic oncologist whose research centers on improving surgical precision and outcomes in endometrial cancer. Her most impactful work, a randomized controlled trial comparing indocyanine green (ICG) with methylene blue for sentinel lymph node detection, has garnered 84 citations and fundamentally shifted clinical practice. By demonstrating that ICG significantly outperforms methylene blue in mapping accuracy, Gauthier provided robust evidence for adopting near-infrared fluorescence imaging as the standard of care, reducing the need for more invasive lymphadenectomies. Her contributions extend beyond this landmark study to encompass broader investigations into minimally invasive surgical techniques and lymphatic mapping in gynecologic malignancies. With her work cited extensively in clinical guidelines and subsequent trials, Gauthier has established herself as a key figure in the evolution of sentinel node biopsy, directly improving patient outcomes by lowering morbidity while maintaining oncologic safety. Her research continues to shape how surgeons approach staging and treatment in endometrial cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
84
Total Citations
84
Avg Citations/Paper
🏆 Most Cited Paper
Green versus blue: Randomized controlled trial comparing indocyanine green with methylene blue for sentinel lymph node detection in endometrial cancer
84 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Centre Hospitalier de l’Université de Montréal

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago